Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis

• Status: Terminated
• Trial end date: 2010-02-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the efficacy of Neuroskin Forte in relieving the symptoms of dry skin in adults with psoriasis or eczema.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Medicine and Dentistry of New Jersey
• Collaborator: AVVAA World Healthcare Products, Inc.

Criteria

Inclusion Criteria

• Must be at least 18 years of age

• Have psoriasis or eczema on both sides of the body, with a pair of roughly symmetrical bilateral "target" lesions at least 1.5 cm in diameter

Exclusion Criteria

• Inability to understand the consent form and/or comply with the requirements of this study

• Use of moisturizers/emollients within 2 days of beginning study